SEC 13F Intelligence

Dsc Advisors, L.P. / BMRN

Dsc Advisors, L.P.’s Biomarin Pharmaceutical Inc Position

Does Dsc Advisors, L.P. own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 99.0K shares worth $9M in Q1 2024; the fund’s latest 13F (Q3 2024) no longer reports it.

Position Value
$9M
Q1 2024
Shares
99.0K
% of Portfolio
+13.81%
Quarters Held
10
position exited

Position History BMRN

Reported value by quarter
Q4 ’21: $6MQ4 ’21Q1 ’22: $6MQ2 ’22: $7MQ2 ’22Q3 ’22: $7MQ4 ’22: $9MQ4 ’22Q1 ’23: $9MQ2 ’23: $9MQ2 ’23Q3 ’23: $9MQ4 ’23: $10MQ4 ’23Q1 ’24: $9Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202499.0K$9M+13.81%
Q4 2023100.0K$10M+15.93%
Q3 2023100.0K$9M+11.36%
Q2 2023100.0K$9M+13.00%
Q1 202392.5K$9M+7.85%
Q4 202282.5K$9M+19.62%
Q3 202282.5K$7M+7.21%
Q2 202282.5K$7M+6.83%
Q1 202280.0K$6M+2.12%
Q4 202170.0K$6M+4.78%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dsc Advisors, L.P.’s full portfolio or all institutional holders of BMRN.